195 related articles for article (PubMed ID: 29952132)
1. α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10.
Li HK; Sugyo A; Tsuji AB; Morokoshi Y; Minegishi K; Nagatsu K; Kanda H; Harada Y; Nagayama S; Katagiri T; Nakamura Y; Higashi T; Hasegawa S
Cancer Sci; 2018 Jul; 109(7):2302-2309. PubMed ID: 29952132
[TBL] [Abstract][Full Text] [Related]
2. FZD10-targeted α-radioimmunotherapy with
Sudo H; Tsuji AB; Sugyo A; Harada Y; Nagayama S; Katagiri T; Nakamura Y; Higashi T
Cancer Sci; 2022 Feb; 113(2):721-732. PubMed ID: 34935247
[TBL] [Abstract][Full Text] [Related]
3. A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
Giraudet AL; Cassier PA; Iwao-Fukukawa C; Garin G; Badel JN; Kryza D; Chabaud S; Gilles-Afchain L; Clapisson G; Desuzinges C; Sarrut D; Halty A; Italiano A; Mori M; Tsunoda T; Katagiri T; Nakamura Y; Alberti L; Cropet C; Baconnier S; Berge-Montamat S; Pérol D; Blay JY
BMC Cancer; 2018 Jun; 18(1):646. PubMed ID: 29884132
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10.
Fukukawa C; Hanaoka H; Nagayama S; Tsunoda T; Toguchida J; Endo K; Nakamura Y; Katagiri T
Cancer Sci; 2008 Feb; 99(2):432-40. PubMed ID: 18271942
[TBL] [Abstract][Full Text] [Related]
5. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
6. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
[TBL] [Abstract][Full Text] [Related]
7. Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B.
Li HK; Hasegawa S; Nakajima NI; Morokoshi Y; Minegishi K; Nagatsu K
Biochem Biophys Res Commun; 2018 Dec; 506(4):1078-1084. PubMed ID: 30409432
[TBL] [Abstract][Full Text] [Related]
8. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with
Bäck T; Chouin N; Lindegren S; Kahu H; Jensen H; Albertsson P; Palm S
J Nucl Med; 2017 Apr; 58(4):598-604. PubMed ID: 27688477
[TBL] [Abstract][Full Text] [Related]
9. 3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma.
Sarrut D; Badel JN; Halty A; Garin G; Perol D; Cassier P; Blay JY; Kryza D; Giraudet AL
EJNMMI Phys; 2017 Dec; 4(1):6. PubMed ID: 28101733
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity.
Hanaoka H; Katagiri T; Fukukawa C; Yoshioka H; Yamamoto S; Iida Y; Higuchi T; Oriuchi N; Paudyal B; Paudyal P; Nakamura Y; Endo K
Ann Nucl Med; 2009 Jul; 23(5):479-85. PubMed ID: 19412654
[TBL] [Abstract][Full Text] [Related]
11. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of three chelates reveals DOTAGA promising for
Sudo H; Tsuji AB; Sugyo A; Harada Y; Nagayama S; Katagiri T; Nakamura Y; Higashi T
Cancer Sci; 2023 Dec; 114(12):4677-4690. PubMed ID: 37781962
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.
Cheng J; Ekberg T; Engström M; Nestor M; Jensen HJ; Tolmachev V; Anniko M
Laryngoscope; 2007 Jun; 117(6):1013-8. PubMed ID: 17440426
[TBL] [Abstract][Full Text] [Related]
15. Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images.
Akabani G; Kennel SJ; Zalutsky MR
J Nucl Med; 2003 May; 44(5):792-805. PubMed ID: 12732682
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the alpha-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodies.
Robinson MK; Shaller C; Garmestani K; Plascjak PS; Hodge KM; Yuan QA; Marks JD; Waldmann TA; Brechbiel MW; Adams GP
Clin Cancer Res; 2008 Feb; 14(3):875-82. PubMed ID: 18245551
[TBL] [Abstract][Full Text] [Related]
17. Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
Chen Y; Kornblit B; Hamlin DK; Sale GE; Santos EB; Wilbur DS; Storer BE; Storb R; Sandmaier BM
Blood; 2012 Feb; 119(5):1130-8. PubMed ID: 22134165
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
Kelly MP; Lee ST; Lee FT; Smyth FE; Davis ID; Brechbiel MW; Scott AM
Prostate; 2009 Jan; 69(1):92-104. PubMed ID: 18942092
[TBL] [Abstract][Full Text] [Related]
19. Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotin.
Yao Z; Zhang M; Garmestani K; Axworthy DB; Mallett RW; Fritzberg AR; Theodore LJ; Plascjak PS; Eckelman WC; Waldmann TA; Pastan I; Paik CH; Brechbiel MW; Carrasquillo JA
Clin Cancer Res; 2004 May; 10(9):3137-46. PubMed ID: 15131055
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
